Condition
Cardiovascular Disease (CVD) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Cardiovascular Disease (CVD) clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Thailand (1), France (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Cardiovascular Disease (CVD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Cardiovascular Risk in Thai MASLD Patients: Coronary Calcium Scores | — | Bangkok, Bangkoknoi | Recruiting | Oct 8, 2026 |
| Understanding aldosterone in hypertension among Kaiser Permanente members | — | Oakland, California | Recruiting | Aug 21, 2026 |
| Monitoring progression of chronic cardiovascular conditions | — | Chicago, Illinois | Recruiting | Feb 19, 2026 |
| Initial dual oral therapy versus monotherapy for PAH with cardiovascular comorbidities | Phase 3 | Le Kremlin-Bicêtre | Recruiting | Nov 24, 2025 |
| Cardiovascular effects of gender-affirming hormones in adults | — | Bologna, BO | Recruiting | Sep 23, 2025 |
All recruiting trials (5)
-
Cardiovascular Risk in Thai MASLD Patients: Coronary Calcium Scores
This study tests how well common cardiovascular risk tools align with coronary calcium scores in Thai adults with MASLD who have no heart symptoms.
-
Understanding aldosterone in hypertension among Kaiser Permanente members
This is an observational program to see how aldosterone relates to high blood pressure in adults with hypertension, using data from Kaiser Permanente members in Northern California.
-
Monitoring progression of chronic cardiovascular conditions
This project will collect wearable physiologic data from adults with cardiovascular conditions to see how their heart disease changes over time.
-
Initial dual oral therapy versus monotherapy for PAH with cardiovascular comorbidities
This trial will test whether starting both tadalafil and ambrisentan together works better than tadalafil alone for people newly diagnosed with pulmonary arterial hypertension who have at least two heart or vascular health problems.
-
Cardiovascular effects of gender-affirming hormones in adults
This project tests whether masculinizing or feminizing gender-affirming hormone therapy changes heart and blood vessel health in transgender adults who have been on hormones for at least 12 months.
Related topics
Quick answers
How many Cardiovascular Disease (CVD) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Thailand (1 trial), France (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.